Concord Biotech fixes 4 Nov 2026 record date for 1:1 bonus issue

The bonus issue in numbers

The record date and bonus ratio

The Board of Directors fixed Wednesday, 4 Nov 2026 as the record date at its meeting held on 27 Oct 2026. The record date determines which shareholders are eligible for bonus equity shares in the ratio of 1:1, meaning one equity share for every one fully paid-up equity share held.

The filing is a continuation of a disclosure the company made on 23 Sep 2026.

The deemed date of allotment

Based on the record date, Thursday, 5 Nov 2026 is the deemed date of allotment of the bonus equity shares, under the SEBI framework the filing cites. The bonus issue is subject to statutory and regulatory approvals, as applicable.

What the bonus issue means for Concord Biotech's shareholders

Shareholders on the record date would receive bonus equity shares at the stated ratio, and the share count they hold would rise accordingly. The filing does not say how many bonus shares will be issued in total, which reserves or share capital will be capitalised, when the shares will be credited to demat accounts, or whether the approvals have been received.

The next dated step is the record date of 4 Nov 2026.

Reference: Original filing (PDF)